BlinkAid
Wearable Device for Blink Monitoring and Prevention of Dry-eye-syndrome
Company Overview
Snapshot
Founded in November 2022 by Yechiam Sapir and Raz Karl, BlinkAid operates with 1–10 employees. The company has secured funding across one round from one investor. In June 2023, BlinkAid received funding from Galil Ofek.
Business overview
BlinkAid is a Health Tech & Life Sciences company developing a wearable application designed to prevent and alleviate the burden of Dry Eye and Computer Vision Syndromes. Its core technology utilizes a patent-protected system embedded into personal glasses to monitor blink rates and quality, employing highly specific and tailored neurostimulation to compensate for improper blinking. BlinkAid aims to be the first to leverage glasses for medical aid beyond vision correction, specifically addressing Dry Eye Symptoms through the natural blinking mechanism. The company serves patients and consumers within the healthcare and medical devices industries.
Strategic signal
In September 2024, BlinkAid was featured in a news article by Ynet.co.il, highlighting its innovative approach to solving dry eye syndrome without traditional drops. This media coverage signals growing recognition for BlinkAid's non-invasive, wearable technology within the ophthalmology and health tech sectors, suggesting potential for market adoption and strategic partnerships as the company's R&D progresses.
Log in to access full profile ›Company Intelligence Q&A
- When was BlinkAid founded?
- BlinkAid was founded in November 2022 by co-founders Yechiam Sapir and Raz Karl.
- What is BlinkAid's primary focus?
- BlinkAid focuses on developing a wearable application to prevent and alleviate Dry Eye and Computer Vision Syndromes by monitoring blink rates and providing neurostimulation through smart glasses.
- Which investor participated in BlinkAid's funding round?
- In June 2023, Galil Ofek participated in BlinkAid's Seed funding round.
- What is the core technology behind BlinkAid's solution?
- BlinkAid's solution uses a patented technology embedded in glasses frames to monitor blink rate and quality, providing highly specific and tailored neurostimulation to address improper blinking.
- What market problem does BlinkAid aim to solve?
- BlinkAid aims to address Dry Eye and Computer Vision Syndromes by leveraging the natural mechanism of blinking, offering a non-invasive alternative to traditional treatments.